210 related articles for article (PubMed ID: 26528138)
1. Lysosomal and phagocytic activity is increased in astrocytes during disease progression in the SOD1 (G93A) mouse model of amyotrophic lateral sclerosis.
Baker DJ; Blackburn DJ; Keatinge M; Sokhi D; Viskaitis P; Heath PR; Ferraiuolo L; Kirby J; Shaw PJ
Front Cell Neurosci; 2015; 9():410. PubMed ID: 26528138
[TBL] [Abstract][Full Text] [Related]
2. Microglia RAGE exacerbates the progression of neurodegeneration within the SOD1
MacLean M; Juranek J; Cuddapah S; López-Díez R; Ruiz HH; Hu J; Frye L; Li H; Gugger PF; Schmidt AM
J Neuroinflammation; 2021 Jun; 18(1):139. PubMed ID: 34130712
[TBL] [Abstract][Full Text] [Related]
3. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G
Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555
[TBL] [Abstract][Full Text] [Related]
4. Connexin 43 in astrocytes contributes to motor neuron toxicity in amyotrophic lateral sclerosis.
Almad AA; Doreswamy A; Gross SK; Richard JP; Huo Y; Haughey N; Maragakis NJ
Glia; 2016 Jul; 64(7):1154-69. PubMed ID: 27083773
[TBL] [Abstract][Full Text] [Related]
5. In-vivo effects of knocking-down metabotropic glutamate receptor 5 in the SOD1
Bonifacino T; Cattaneo L; Gallia E; Puliti A; Melone M; Provenzano F; Bossi S; Musante I; Usai C; Conti F; Bonanno G; Milanese M
Neuropharmacology; 2017 Sep; 123():433-445. PubMed ID: 28645622
[TBL] [Abstract][Full Text] [Related]
6. Transcriptomic indices of fast and slow disease progression in two mouse models of amyotrophic lateral sclerosis.
Nardo G; Iennaco R; Fusi N; Heath PR; Marino M; Trolese MC; Ferraiuolo L; Lawrence N; Shaw PJ; Bendotti C
Brain; 2013 Nov; 136(Pt 11):3305-32. PubMed ID: 24065725
[TBL] [Abstract][Full Text] [Related]
7. Modulation of astrocytic mitochondrial function by dichloroacetate improves survival and motor performance in inherited amyotrophic lateral sclerosis.
Miquel E; Cassina A; Martínez-Palma L; Bolatto C; Trías E; Gandelman M; Radi R; Barbeito L; Cassina P
PLoS One; 2012; 7(4):e34776. PubMed ID: 22509356
[TBL] [Abstract][Full Text] [Related]
8. Toll-Like Receptor-4 Inhibitor TAK-242 Attenuates Motor Dysfunction and Spinal Cord Pathology in an Amyotrophic Lateral Sclerosis Mouse Model.
Fellner A; Barhum Y; Angel A; Perets N; Steiner I; Offen D; Lev N
Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28763002
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the Mitochondrial Aerobic Metabolism in the Pre- and Perisynaptic Districts of the SOD1
Ravera S; Bonifacino T; Bartolucci M; Milanese M; Gallia E; Provenzano F; Cortese K; Panfoli I; Bonanno G
Mol Neurobiol; 2018 Dec; 55(12):9220-9233. PubMed ID: 29656361
[TBL] [Abstract][Full Text] [Related]
10. CNS-derived extracellular vesicles from superoxide dismutase 1 (SOD1)
Silverman JM; Christy D; Shyu CC; Moon KM; Fernando S; Gidden Z; Cowan CM; Ban Y; Stacey RG; Grad LI; McAlary L; Mackenzie IR; Foster LJ; Cashman NR
J Biol Chem; 2019 Mar; 294(10):3744-3759. PubMed ID: 30635404
[TBL] [Abstract][Full Text] [Related]
11. Early gene expression changes in spinal cord from SOD1(G93A) Amyotrophic Lateral Sclerosis animal model.
de Oliveira GP; Alves CJ; Chadi G
Front Cell Neurosci; 2013; 7():216. PubMed ID: 24302897
[TBL] [Abstract][Full Text] [Related]
12. Altered Metabolic Profiles Associate with Toxicity in SOD1
Valbuena GN; Tortarolo M; Bendotti C; Cantoni L; Keun HC
Sci Rep; 2017 Mar; 7(1):50. PubMed ID: 28246392
[TBL] [Abstract][Full Text] [Related]
13. GLT1 overexpression in SOD1(G93A) mouse cervical spinal cord does not preserve diaphragm function or extend disease.
Li K; Hala TJ; Seetharam S; Poulsen DJ; Wright MC; Lepore AC
Neurobiol Dis; 2015 Jun; 78():12-23. PubMed ID: 25818008
[TBL] [Abstract][Full Text] [Related]
14. Spinal motoneurones are intrinsically more responsive in the adult G93A SOD1 mouse model of amyotrophic lateral sclerosis.
Jensen DB; Kadlecova M; Allodi I; Meehan CF
J Physiol; 2020 Oct; 598(19):4385-4403. PubMed ID: 32716521
[TBL] [Abstract][Full Text] [Related]
15. Spinal Cord Metabolic Signatures in Models of Fast- and Slow-Progressing SOD1
Valbuena GN; Cantoni L; Tortarolo M; Bendotti C; Keun HC
Front Neurosci; 2019; 13():1276. PubMed ID: 31920474
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of Abeta is associated with acceleration of onset of motor impairment and superoxide dismutase 1 aggregation in an amyotrophic lateral sclerosis mouse model.
Li QX; Mok SS; Laughton KM; McLean CA; Volitakis I; Cherny RA; Cheung NS; White AR; Masters CL
Aging Cell; 2006 Apr; 5(2):153-65. PubMed ID: 16626394
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial dysfunction in SOD1G93A-bearing astrocytes promotes motor neuron degeneration: prevention by mitochondrial-targeted antioxidants.
Cassina P; Cassina A; Pehar M; Castellanos R; Gandelman M; de León A; Robinson KM; Mason RP; Beckman JS; Barbeito L; Radi R
J Neurosci; 2008 Apr; 28(16):4115-22. PubMed ID: 18417691
[TBL] [Abstract][Full Text] [Related]
18. Autophagy activation and neuroprotection by progesterone in the G93A-SOD1 transgenic mouse model of amyotrophic lateral sclerosis.
Kim J; Kim TY; Cho KS; Kim HN; Koh JY
Neurobiol Dis; 2013 Nov; 59():80-5. PubMed ID: 23891729
[TBL] [Abstract][Full Text] [Related]
19. PACAP signaling exerts opposing effects on neuroprotection and neuroinflammation during disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Ringer C; Büning LS; Schäfer MK; Eiden LE; Weihe E; Schütz B
Neurobiol Dis; 2013 Jun; 54():32-42. PubMed ID: 23466699
[TBL] [Abstract][Full Text] [Related]
20. Altered glucose catabolism in the presynaptic and perisynaptic compartments of SOD1
Ravera S; Torazza C; Bonifacino T; Provenzano F; Rebosio C; Milanese M; Usai C; Panfoli I; Bonanno G
J Neurochem; 2019 Nov; 151(3):336-350. PubMed ID: 31282572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]